Validus Pharmaceuticals
UEI: DGS6X5SN99Z6
• CAGE: 4W8M6
Overview
Awardee Type
Parent
Company Description
Validus is focused on acquiring, reformulating, and marketing prescription products in specialty therapeutic areas. Our business is based on acquisition of established products that are FDA-approved and satisfy unmet clinical needs.
Name
Validus Pharmaceuticals
Website
Headquarters
Parsippany, NJ
United States
United States
Federal recipient
VALIDUS PHARMACEUTICALS, LLC
(UEI DGS6X5SN99Z6, CAGE 4W8M6)
is headquartered in Parsippany NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 2007 and
federally registered in
October 2007.
Federal Registration and Certifications
Legal Name
VALIDUS PHARMACEUTICALS, LLC
UEI
DGS6X5SN99Z6
CAGE Code
4W8M6
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 6, 2007
Initial Registration
Oct. 4, 2007
Last Registration
Oct. 30, 2024
Registration Activation
Oct. 30, 2024
Registration Expiration
Oct. 29, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Manufacturer of Goods
Limited Liability Company
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Validus Pharmaceuticals
GSA Schedules and Price Lists
- Validus Pharmaceuticals
- PoP: 3/31/23 - 3/31/28
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Validus Pharmaceuticals
- PoP: 4/30/13 - 4/1/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)